Consultant Endocrinologist and Physician at Royal Lancaster Infirmary, United Kingdom
Dr. Mohamed Nabil Elnaggar is an esteemed consultant and researcher specializing in diabetes, endocrinology, and lipidology. With a career spanning various prestigious institutions, he is recognized for his clinical expertise and contributions to medical research. Dr. Elnaggar’s work integrates extensive clinical practice with innovative research, enhancing patient care and advancing the field of endocrinology. He is currently a leading figure in lipidology and diabetes management, holding significant roles in both clinical and academic settings.
Profile
GOOGLE SCHOLAR
Education
Dr. Elnaggar’s academic journey is marked by an impressive array of qualifications. He completed his MBChB at Alexandria University with honors and pursued further studies to earn an MSc and a PhD in Internal Medicine from Alexandria Faculty of Medicine. His postgraduate education includes obtaining membership of the Royal College of Physicians (MRCP UK) and a Subspecialty certificate in Diabetes and Endocrinology. He has also maintained current expertise through multiple certifications in Good Clinical Practice (GCP).
Experience
Dr. Elnaggar has extensive clinical experience across various hospitals and institutions. He has worked as an Internal Medicine Specialist and Consultant in several renowned facilities, including Alexandria Main University Hospital and University Hospitals of Morecambe Bay. His roles have included leading the Diabetes and Endocrinology Unit and the Lipid service. In addition to his clinical work, he has served as a lecturer and consultant, contributing to both the education of future medical professionals and the advancement of clinical practice.
Research Interest
Dr. Elnaggar’s research interests lie primarily in diabetes management, lipid disorders, and endocrinology. His work focuses on improving treatment strategies for complex conditions such as familial dyslipidemias and type 2 diabetes, particularly in the context of Ramadan fasting and new therapeutic interventions. He is involved in a variety of clinical trials and research studies aimed at enhancing understanding and management of these conditions.
Awards
Dr. Elnaggar has been recognized for his contributions to the field of medicine through various accolades and awards. His dedication to research and clinical excellence has been acknowledged by his peers and the broader medical community, highlighting his role as a leading researcher and clinician in diabetes and lipidology.
Publications
Primary Hyperparathyroidism: Findings from the Retrospective Evaluation of Cases Over a 6-Year Period from a Regional UK Centre – Endocrine, 2018. Cited by 18 articles.
Amiodarone-Induced Thyroid Dysfunction: A Clinical Update – Experimental and Clinical Endocrinology & Diabetes, 2018. Cited by 22 articles.
Alpha-cells: Its Role as the Islet Harmonizer – International Journal of Diabetes and Endocrinology, 2019. Cited by 5 articles.
Senescence and Diabetes: A Mini Review – EC Endocrinology and Metabolic Research, 2020. Cited by 8 articles.
Hyponatraemic Seizure Secondary to Primary Polydipsia Following Urological Surgery – BMJ Case Reports, 2022. Cited by 2 articles.
Protein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies (PCSK9mab) in Clinical Practice at Secondary Care – Real World Multicentre Experience – Cureus, 2022. Cited by 4 articles.
Conclusion:
Mohamed Nabil Elnaggar is a highly deserving candidate for the Best Researcher Award based on his substantial contributions to the fields of diabetes, endocrinology, and lipidology. His extensive education, substantial clinical experience, and significant involvement in research and teaching position him as a leader in his field. Addressing the identified areas for improvement, such as increasing publication impact and diversifying research topics, could further strengthen his candidacy and amplify his contributions to medical science. Overall, Mohamed’s achievements and ongoing efforts make him an excellent candidate for the award.